Document is current
Any future updates will be listed below
-
Authors
Fabian, Alexander
Buergy, Daniel
Weykamp, Fabian
Hörner-Rieber, Juliane
Bernhardt, Denise
Boda-Heggemann, Judit
Pazos, Montserrat
Mehrhof, Nora
Kaul, David
Bicu, Alicia S.
Badra, Eugenia Vlaskou
Rogers, Susanne
Janssen, Stefan
Hemmatazad, Hossein
Hintelmann, Katharina
Gkika, Eleni
Lange, Tim
Ferentinos, Konstantinos
Karle, Heiko
Brunner, Thomas
Wittig, Andrea
Nona-Duma, Marciana
Blanck, Oliver
Krug, David
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 9 December 2024
First Online: 21 December 2024
Declarations
:
: AF has received honoraria from Merck Sharp & Dome. DKa has received research funding from Merck KGaA and Deutsche Krebshilfe; DKr has received honoraria from Astra Zeneca, best practice onkologie, ESO, ESMO, Gilead, medupdate, Merck Sharp & Dohme, Novartis, onkowissen.TV and Pfizer; EG has received honoraria from Astra Zeneca, Novocure, IntraOp and research funding from Astra Zeneca, Novocure, IntraOp and Deutsche Krebshilfe; FW received speaker fees from AstraZeneca, Varian Medical Systems and Merck Sharp & Dohme and travel support for attending meetings from Varian Medical Systems, Novocure GmbH, Fraunhofer MEVIS and Micropos Medical as well as compensation for advisory boards from Novocure GmbH and Merck Sharp & Dohme; JHR received speaker fees from Pfizer Inc., Astra Zeneca, Sanofi and ViewRay Inc., travel reimbursement from Varian Medical Systems as well as research grants from IntraOP Medical and Varian Medical Systems outside the submitted work; MND has received speaker honoraria from Astra Zeneca outside the scope of this study All other authors have no competing interests to declare.
: Approval from local ethics committees was acquired for each participating center after approval for the leading study center (Kiel, Germany D582/20).
